Ligand Pharmaceuticals | LGND - 販売収入





セールス 変化する 日付
Agenus USD 34.2M 3.97M 2025-12
Amgen USD 9.9B 340M 2025-12
Anika Therapeutics USD 30.62M 2.8M 2025-12
Arrowhead Research USD 264.03M 7.56M 2025-12
Baxter International USD 2.97B 130M 2025-12
Bristol-Myers Squibb USD 12.5B 300M 2025-12
Eli Lilly USD 19.3B 1.7B 2025-12
Enanta Pharmaceuticals USD 16.96M 50.68M 2024-12
Enviri Corporation USD 555M 19.81M 2025-12
Gilead Sciences USD 7.93B 130M 2025-12
GlaxoSmithKline GBP 8.62B 73M 2025-12
Glaxosmithkline GBP 11.46B 59.16M 2025-12
Heron Therapeutics USD 40.59M 2.38M 2025-12
Insmed USD 263.8M 121.8M 2025-12
Intrexon USD 717K 511K 2024-06
Ionis Pharmaceuticals USD 203M 46M 2025-12
Karyopharm Therapeutics USD 34.08M 3.54M 2025-12
Ligand Pharmaceuticals USD 59.66M 55.8M 2025-12
MacroGenics USD 41.23M 31.61M 2025-12
Merck USD 16.4B 880M 2025-12
Pacira USD 196.87M 17.35M 2025-12
Pfizer USD 17.58B 880M 2025-12
Rigel Pharmaceuticals USD 55.31M 18.47M 2024-09
Sangamo BioSciences USD 356K 125K 2024-06
Veracyte USD 140.6M 8.7M 2025-12